Adiponectin and its potential in the treatment of obesity, diabetes and insulin resistance
- PMID: 16259219
Adiponectin and its potential in the treatment of obesity, diabetes and insulin resistance
Abstract
Adiponectin is a protein hormone produced exclusively by adipocytes. Its circulating levels are decreased in individuals with obesity, atherosclerosis and insulin resistance, suggesting that its deficiency may have a causal role in the etiopathogenesis of these diseases. Studies have shown that adiponectin administration in rodents has insulin-sensitizing, anti-atherogenic and anti-inflammatory effects and under certain settings also decreases body weight. Therefore, adiponectin replacement in humans may represent a promising approach to prevent and/or treat obesity, insulin resistance and type 2 diabetes; however, clinical studies with adiponectin administration need to be conducted to confirm this hypothesis. Current experimental and clinical data regarding adiponectin physiology and pathophysiology are detailed in this review.
Similar articles
-
Adiponectin, obesity, and cardiovascular disease.Biochimie. 2004 Nov;86(11):779-84. doi: 10.1016/j.biochi.2004.09.016. Biochimie. 2004. PMID: 15589686 Review.
-
The role of adiponectin in obesity, diabetes, and cardiovascular disease.J Cardiometab Syndr. 2009 Winter;4(1):44-9. doi: 10.1111/j.1559-4572.2008.00030.x. J Cardiometab Syndr. 2009. PMID: 19245516 Review.
-
Recent advances in the relationship between obesity, inflammation, and insulin resistance.Eur Cytokine Netw. 2006 Mar;17(1):4-12. Eur Cytokine Netw. 2006. PMID: 16613757 Review.
-
[Adiponectin and its role in the pathogenesis of obesity, diabetes mellitus and insulin resistance].Pol Merkur Lekarski. 2006 Mar;20(117):355-7. Pol Merkur Lekarski. 2006. PMID: 16780274 Review. Polish.
-
Comparison of body fat composition and serum adiponectin levels in diabetic obesity and non-diabetic obesity.Obesity (Silver Spring). 2006 Jul;14(7):1164-71. doi: 10.1038/oby.2006.133. Obesity (Silver Spring). 2006. PMID: 16899797
Cited by
-
Chemerin, a novel peroxisome proliferator-activated receptor gamma (PPARgamma) target gene that promotes mesenchymal stem cell adipogenesis.J Biol Chem. 2011 Jul 8;286(27):23982-95. doi: 10.1074/jbc.M111.220491. Epub 2011 May 14. J Biol Chem. 2011. PMID: 21572083 Free PMC article.
-
Adipose tissue autophagy and homeostasis in alcohol-induced liver injury.Liver Res. 2017 Jun;1(1):54-62. doi: 10.1016/j.livres.2017.03.004. Epub 2017 Apr 26. Liver Res. 2017. PMID: 29109891 Free PMC article.
-
Adiponectin and pro-inflammatory cytokines are modulated in Vietnamese patients with type 2 diabetes mellitus.J Diabetes Investig. 2017 May;8(3):295-305. doi: 10.1111/jdi.12579. Epub 2016 Oct 30. J Diabetes Investig. 2017. PMID: 27684566 Free PMC article.
-
Association of adiponectin gene (ADIPOQ) rs2241766 polymorphism with obesity in adults: a meta-analysis.PLoS One. 2014 Apr 16;9(4):e95270. doi: 10.1371/journal.pone.0095270. eCollection 2014. PLoS One. 2014. PMID: 24740426 Free PMC article.
-
Effect of liraglutide on anthropometric measurements, sagittal abdominal diameter and adiponectin levels in people with type 2 diabetes treated with multiple daily insulin injections: evaluations from a randomized trial (MDI-liraglutide study 5).Obes Sci Pract. 2019 Mar 18;5(2):130-140. doi: 10.1002/osp4.324. eCollection 2019 Apr. Obes Sci Pract. 2019. PMID: 31019730 Free PMC article.